Brivanib Metastatic Renal Cell Carcinoma
Clinical trial NCT01253668 · TERMINATED
Trial details
- NCT number
- NCT01253668
- Sponsor
- Abramson Cancer Center at Penn Medicine
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-11-01
- Primary completion
- 2013-09-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.